Longzhen Cui
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Biochemistry top 5%
- Sulfur Compounds in Biology
Papers in
- Hematology 24
- Acute Myeloid Leukemia Research 19
- Multiple Myeloma Research and Treatments 5
-
- MicroRNA in disease regulation 2
- Cancer, Hypoxia, and Metabolism 1
- Co-authors
- Lin Na Fu (24 shared papers)Yan Liu (22 shared papers)Tingting Qian (20 shared papers)Zhiheng Cheng (18 shared papers)Yifan Pang (10 shared papers)Liang Quan (12 shared papers)Jinlong Shi (11 shared papers)Xiaoyan Ke (3 shared papers)
- Journals
- Cancer Gene Therapy (6 papers)The Pharmacogenomics Journal (3 papers)Journal of Cellular and Molecular Medicine (2 papers)Frontiers in Oncology (2 papers)Journal of Cancer (2 papers)
- Partner nations
- ChinaNetherlandsUnited States
In The Last Decade
Longzhen Cui
29 papers receiving 686 citations
Peers
Comparison fields: 5 of 55
- Hematology 172
- Biochemistry 80
- Cancer Research 146
- Molecular Biology 220
- Oncology 53
Countries citing papers authored by Longzhen Cui
This map shows the geographic impact of Longzhen Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longzhen Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longzhen Cui more than expected).
Fields of papers citing papers by Longzhen Cui
This network shows the impact of papers produced by Longzhen Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longzhen Cui. The network helps show where Longzhen Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Longzhen Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 174 | |
| 2 | 2017 | 110 | |
| 3 | 2018 | 41 | |
| 4 | 2019 | 33 | |
| 5 | 2020 | 33 | |
| 6 | 2019 | 30 | |
| 7 | 2019 | 25 | |
| 8 | 2019 | 22 | |
| 9 | 2018 | 21 | |
| 10 | 2019 | 20 | |
| 11 | 2021 | 20 | |
| 12 | 2020 | 19 | |
| 13 | 2018 | 18 | |
| 14 | 2019 | 18 | |
| 15 | 2022 | 15 | |
| 16 | 2020 | 14 | |
| 17 | 2017 | 13 | |
| 18 | Prognostic value of the PDLIM family in acute myeloid leukemia. | 2019 | 11 |
| 19 | 2020 | 11 | |
| 20 | 2019 | 8 |
About Longzhen Cui
Longzhen Cui is a scholar working on Hematology, Cancer Research, Biochemistry, Molecular Biology and Oncology, having authored 29 papers that have together received 692 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (19 papers), Multiple Myeloma Research and Treatments (5 papers), MicroRNA in disease regulation (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Lung Cancer Research Studies (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Sulfur Compounds in Biology (1 paper). The work is most often cited by research in Hematology (172 citations), Biochemistry (80 citations), Cancer Research (146 citations), Molecular Biology (220 citations) and Oncology (53 citations). Longzhen Cui has collaborated with scholars based in China, Netherlands and United States. Frequent co-authors include Lin Na Fu, Yan Liu, Tingting Qian, Zhiheng Cheng, Yifan Pang, Liang Quan, Jinlong Shi, Xiaoyan Ke, Yifeng Dai and Hongyou Zhao. Their work appears in journals such as Cancer Gene Therapy, The Pharmacogenomics Journal, Journal of Cellular and Molecular Medicine, Frontiers in Oncology and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.